The use of hydroxychloroquine in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency requires caution due to the risk of hemolytic anemia.
hydroxychloroquine 200 mg tablet G6PD deficiency is a genetic disorder that affects the red blood cells' ability to withstand oxidative stress, and certain medications, including hydroxychloroquine, can trigger hemolysis in susceptible individuals. Healthcare providers should screen patients for G6PD deficiency before initiating treatment and monitor for signs of hemolytic anemia during therapy.
